Trial intelligence / Profile preview

Immediate vs Delayed Treatment of Odontogenic Infections

NCT04057014Phase 4Withdrawn

Sponsor
Boston Children's Hospital
Start
Oct 2020
Primary completion
Oct 2020
Modality
Small Molecules
01

Overview

A Phase 4 trial of amoxicillin in odontogenic infection (OI), sponsored by Boston Children's Hospital. Planned start Oct 2020; status: withdrawn.

02

Drugs

amoxicillin
03

Conditions

odontogenic infection (OI)

Beyond the preview

Go deeper on NCT04057014.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04057014.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call